Mico BioMed Co. Ltd. (214610) — Financial Flexibility Index
Mico BioMed Co. Ltd. (214610) has a Financial Flexibility Index of -1.03x as of September 2025. Free cash flow of ₩-8.13 Billion (operating CF ₩-8.13 Billion minus capex ₩0.00) represents -1% of total liabilities (₩7.88 Billion). Check Mico BioMed Co. Ltd. (214610) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mico BioMed Co. Ltd. Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Mico BioMed Co. Ltd. across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Mico BioMed Co. Ltd. generate cash.
Annual Financial Flexibility Index for Mico BioMed Co. Ltd. (2016–2024)
Year-by-year free cash flow to debt coverage for Mico BioMed Co. Ltd.. Explore 214610 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.34x | ₩-9.71 Billion | ₩-10.70 Billion | ₩28.58 Billion | ▲ +20.5% |
| 2023 | -0.43x | ₩-10.68 Billion | ₩-11.36 Billion | ₩24.99 Billion | ▼ -37.4% |
| 2022 | -0.31x | ₩-12.38 Billion | ₩-14.01 Billion | ₩39.82 Billion | ▼ -96.6% |
| 2021 | -0.16x | ₩-5.76 Billion | ₩-8.60 Billion | ₩36.42 Billion | ▲ +81.6% |
| 2020 | -0.86x | ₩-12.92 Billion | ₩-18.68 Billion | ₩15.00 Billion | ▼ -127.4% |
| 2019 | -0.38x | ₩-9.10 Billion | ₩-10.43 Billion | ₩24.01 Billion | ▼ -41.7% |
| 2018 | -0.27x | ₩-4.93 Billion | ₩-6.79 Billion | ₩18.45 Billion | ▼ -43.0% |
| 2017 | -0.19x | ₩-2.43 Billion | ₩-2.89 Billion | ₩13.02 Billion | ▲ +72.1% |
| 2016 | -0.67x | ₩-3.79 Billion | ₩-3.99 Billion | ₩5.65 Billion | — |